The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Management of long-term hypothyroidism: a potential marker of quality of medicines reconciliation in the intensive care unit
Open accessAbstract
OBJECTIVE: Significant errors can be made during medication prescribing, dispensing and administration. One source of error and potential for harm is unintentional omission. Medicines reconciliation seeks to reduce the impact of this between transfer of care. In long-term hypothyroidism, patients are dependent upon levothyroxine and there are few contraindications to its prescription. We considered levothyroxine prescription in long-term hypothyroidism as a marker of medicines reconciliation on admission and during stay in the intensive care unit (ICU). METHODS: A retrospective chart review was undertaken in a tertiary referral university ICU with all patients who were receiving long-term levothyroxine therapy identified. Notes were reviewed for the presence of thyroid-replacement prescription and for thyroid function tests, in addition to demographic, length of stay and mortality data. KEY FINDINGS: Thyroid-replacement therapy was not prescribed for more than 7 days in 23/133 (17.3%) patients and omitted entirely in three patients. A further 28/133 (21.1%) patients were intolerant of enteral feeding for more than 7 days and were thus unable to have oral levothyroxine administered. None of these patients received parenteral therapy. Thyroid function tests were performed in 104/133 (78.2%) patients. CONCLUSIONS: Prescription of chronic therapy, in this case thyroid-replacement therapy, was inadequate. This highlights the need for a progressive medicines-reconciliation process embedded within the daily ICU programme.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In nine hypothyroid patients who stayed at ICU for 12-45 days and received H2-blockers, after the first 4-8 days at ICU with L-T4 doses unchanged, TSH of all patients increased significantly to 5.69 mU/L (IQR = 3.87-6.83) from 1.52 mU/L (IQR = 0.79-3.8) at admission; L-T4 dose was increased in 8/9 patients (88.9%) from 86.1 ± 41.6 to 125 ± 39.5 μg/d (54.4 ± 31.6%); upon discharge, TSH returned to
“Nine hypothyroid patients who stayed at ICU for 12–45 days received H2-blockers as routine prophylaxis against gastroduodenal bleeding and were nasogastrically fed a calorically dense solution (96). This solution was stopped 2 h before and resumed 2 h after L-T4 administration (crushed tablets) nasogastrically. After the first 4–8 days at ICU, with L-T4 doses unchanged, TSH of all patients”
From L-T4 therapy in the presence of pharmacological interferents (2020) · cites this paper as [96]
The increased L-T4 requirements in ICU patients were attributed to increased gastric pH by H2-blockers (and subsequent decreased L-T4 absorption) and increased T4 to reverse-T3 shunting (due to enhanced type-III deiodinase activity during critical illnesses).
“The increased L-T4 requirements were attributed to increased gastric pH by H2-blockers (and subsequent decreased L-T4 absorption) and increased T4 to reverse-T3 shunting (due to enhanced type-III deiodinase activity during critical illnesses) (96).”
From L-T4 therapy in the presence of pharmacological interferents (2020) · cites this paper as [96]
Among 133 hypothyroid patients hospitalized in intensive care units, thyroid function tests were not performed in 29 (21.8%), replacement therapy was not prescribed for >7 days in 23 (17.3%) and was omitted in three (2.2%).
“Among 133 such patients, TFTs were not performed in 29 (21.8%), replacement therapy was not prescribed for >7 days in 23 (17.3%) and was omitted in three (2.2%) (95).”
From L-T4 therapy in the presence of pharmacological interferents (2020) · cites this paper as [95]
Citations
Cites
Institute of Medicine (2000) · National Academies Press eBooks · doi:10.17226/9728 · Cited by 14,367
To Err is Human: Building a Safer Health System
Hendee, W. R. (2001) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(01)70072-3 · Cited by 10,129
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M. E., Rocca, H. B., Buser, P. T., Rickenbacher, P. R., Hunziker, P., Mueller, C. E., Jeger, R. V., Bader, F., Osswald, S., & Kaiser, C. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Rothschild, J. M., Landrigan, C. P., CRONIN, J. W., Kaushal, R., Lockley, S. W., Burdick, E., Stone, P. H., Lilly, C. M., Katz, J. T., Czeisler, C. A., et al. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000171609.91035.bd · Cited by 925
Gleason, K. M., McDaniel, M. R., Feinglass, J. M., Baker, D. W., Lindquist, L. A., Liss, D. T., & Noskin, G. A. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1256-6 · Cited by 407
Kopp, B. J., Erstad, B. L., Allen, M. E., Theodorou, A. A., & Priestley, G. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000198106.54306.d7 · Cited by 363
Clinical review: Medication errors in critical care
Moyen, E., Camiré, E., & Stelfox, H. T. (2008) · Critical Care · doi:10.1186/cc6813 · Cited by 292
MacLaren, R., Bond, C., Martin, S. J., & Fike, D. S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818f2269 · Cited by 242
The epidemiology and costs of chronic critical illness
Carson, S. S., & Bach, P. B. (2002) · Critical Care Clinics · doi:10.1016/s0749-0704(02)00015-5 · Cited by 201
Callen, J. L., McIntosh, J., & Li, J. (2009) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2009.09.002 · Cited by 156
Incidence of Adverse Drug Events and Medication Errors in Intensive Care Units
Benkirane, R., Abouqal, R., Haimeur, C. C., Kettani, S. S. S. E. C. E., Azzouzi, A., Alaoui, A. A. M., Izgua, A. T., Nejmi, M. M., Maazouzi, W. W., Madani, N., et al. (2009) · Journal of Patient Safety · doi:10.1097/pts.0b013e3181990d51 · Cited by 119
The role of thyroid dysfunction in the critically ill: a review of the literature.
Bello, G., Ceaichisciuc, I., Silva, A. M., & Antonelli, M. M. (2010) · PubMed · Cited by 53
Determination of metformin in biological samples.
Lennard, M., Casey, C., Tucker, G., & Woods, H. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb00852.x · Cited by 50
The epidemiology of critical illness in the elderly
Carson, S. S. (2003) · Critical Care Clinics · doi:10.1016/s0749-0704(03)00051-4 · Cited by 50
Clinical pharmacist on intensive care unit saves lives and reduces costs*
Knibbe, C. A. J., & Tjoeng, M. M. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818bd9c0 · Cited by 15
Wadwekar, D., & Kabadi, U. M. (2004) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2004-821012 · Cited by 12
E-Prescribing First Step to Improved Safety
FINKELSTEIN, J. B. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj519 · Cited by 12
Allergy documentation and transfer within critical care
Hatton, K., Barrett, N. A., Lim, J. S., & McKenzie, C. (2010) · Critical Care · doi:10.1186/cc8683 · Cited by 2
Flagged first, then by citations
1 of the 20 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Corbett, 2010, Improving medicines reconciliation after discharge from a critical care unit, Br J Clin Pharm, 6, 183
Cited by
Sorted by citations
Thyroid function in critically ill patients
Fliers, E., Bianco, A. C., Langouche, L., & Boelen, A. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00225-9 · Cited by 441
Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient’s Lifetime
Duntas, L. H., & Jonklaas, J. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01078-2 · Cited by 99
Optimal thyroid hormone replacement
Jonklaas, J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab031 · Cited by 89
Shulman, R. I., McKenzie, C., Landa, J., Bourne, R. S., Jones, A., Borthwick, M., Tomlin, M., Jani, Y. H., West, D., & Bates, I. P. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.04.008 · Cited by 62
Bourne, R. S., Whiting, P., Brown, L. S., & Borthwick, M. (2015) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12219 · Cited by 26
Eadie, R., McKenzie, C., Hadfield, D., Kalk, N. J., Bolesta, S., Dempster, M., McAuley, D. F., Blackwood, B., & UK ALERT-ICU study investigators (2023) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-023-01614-9 · Cited by 16
Mohammad, R. A., Betthauser, K. D., Bookstaver, R. E., Coe, A. B., Hatton, J., Fritschle, A. C., Jagow, B., Kenes, M. T., MacTavish, P., Slampak-Cindric, A. A., et al. (2020) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1311 · Cited by 15
L-T4 therapy in the presence of pharmacological interferents
Benvenga, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.607446 · Cited by 13
Management of Hypothyroidism in Patients with Acute Myocardial Infarction
Eagan, D., Spencer‐Bonilla, G., Maraka, S., Aggarwal, M., & Ospina, N. S. (2020) · Medicina · doi:10.3390/medicina56050214 · Cited by 11
Bourne, R. S., Ioannides, C. P., Gillies, C., Bull, K. M., Turton, E. C. O., & Bryden, D. C. (2021) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2020-002618 · Cited by 9
Cheng, C.-L., Walsh, A. E. L., Jones, S., Matthews, S., Weerasooriya, D. N. N., Fernandes, R., & McKenzie, C. (2022) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-022-01475-8 · Cited by 9
Clinical Conundrums in Management of Hypothyroidism in Critically Ill Geriatric Patients
Sehgal, V., Bajwa, S. S., Sehgal, R., & Bajaj, A. (2014) · Intern J Endocrinol Metab · doi:10.5812/ijem.13759 · Cited by 6
Kanodia, C., Bourne, R. S., Mansi, E. T., & Lone, N. (2024) · Journal of the Intensive Care Society · doi:10.1177/17511437241230260 · Cited by 4
Advanced therapy medicinal products: a comprehensive overview for pharmacy professionals
McKenzie, C., Chappell, J., Guy, R. H., Hakes, L., Hawksworth, G., Hughes, D., & Black, A. (2022) · Pharmaceutical journal/The pharmaceutical journal · doi:10.1211/pj.2022.1.150934 · Cited by 2
Oyedele, A. (2018) · CRC Press eBooks · doi:10.1201/9781315264974-13 · Cited by 2
McKenzie, C. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001436 · Cited by 1
Remmington, C., Cameron, L., Hanks, F., Liang, Y., Barrow, L., Coxhead, R., Mehta, R., Bhudia, N., Lyster, H. S., Cooke, S., et al. (2024) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-024-01719-9 · Cited by 1
Thyroidal Changes During Critical Illness
Langouche, L., & den Berghe, G. V. (2016) · Springer eBooks · doi:10.1007/978-3-319-27687-8_11 · Cited by 1
Advanced therapy medicinal products: a comprehensive overview for pharmacy professionals
(2022) · Pharmaceutical journal/The pharmaceutical journal · doi:10.1211/pj.2022.1.11576
Metadata
- Authors
- Barrett, N. A., Jones, A., Whiteley, C., Yassin, S., & McKenzie, C. A.
- Affiliations
- St Thomas' Hospital (GB)
- King's College London (GB)
- Corresponding author
- McKenzie, Cathrine A
- Venue
- International Journal of Pharmacy Practice
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-02
- Volume
- 20
- Issue
- 5
- Pages
- 303-306
- ISSN
- 0961-7671 (ISSN-L)
- 2042-7174
- OpenAlex
- W1925981434
- Cited by
- 20
- References
- 20
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2016: 2 · 2015: 4 · 2014: 1
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.scopus.com
- Licence
- Locations
- International Journal of Pharmacy Practice (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Keywords
- levothyroxine, medication reconciliation, intensive care unit, medication omission, thyroid function tests, enteral feeding intolerance, medication errors, quality of care
- MeSH terms
- Administration, Oral, Aged, Enteral Nutrition, Female, Hospitals, University, Humans, Hypothyroidism, Intensive Care Units, Length of Stay, Male, Medication Errors, Patient Admission, Retrospective Studies, Thyroid Function Tests, Thyroxine, Time Factors, Medication Reconciliation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review